Back to Authors

Vilaseca, Andreu

A5138371671 | I4210105047

Mayo Clinic

Autoimmune Technologies (United States)

Citations 1

Tocilizumab as Add-on Therapy for Severe Attacks in NMOSD and MOGAD: A Multicenter Retrospective Case Series (P3-1.009)

Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000217046